GPN Vaccines
PrivateLast Round
Series B
Extension
Jun 5, 2024
Est. Valuation
$300M
Total Funding Raised
$25.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GPN Vaccines is a biotechnology company that develops innovative vaccines designed to provide broad-spectrum protection against Streptococcus pneumoniae and other bacterial pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GPN Vaccines Comparables
Compare GPN Vaccines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNewVax Ltd. | 82% | |
| Inventprise | 80% | |
| Matrivax Research & Development Corporation | 78% |
GPN Vaccines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 5, 2024 | ||||
| Grant | May 7, 2024 | ||||
| Series A Extension | Jan 31, 2023 | ||||
| Series A Extension | Jun 30, 2020 | ||||
| Grant | Apr 10, 2020 | ||||
Seed | Jan 18, 2019 |
GPN Vaccines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forepont Capital Partners | Series A Extension, Series B Extension |
| CUREator | Grant |
| South Australian Early Commercialisation Fund | Grant |
| Astute Ventures | Series A Extension |
| Shearwater Capital | Series B Extension |
| Kern Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Grew 18% QoQ, from 28 to 33 employees.
- Apr 23, 2026
Monthly visitors increased 218% MoM, reaching 4.3K.
Recent news
Latest coverage and updates
- attends_eventSep 28, 2026
GPN Vaccines will present progress at the World Vaccine Congress Europe in Netherlands on Oct 19th-21st '26
- attends_eventSep 28, 2026
GPN Vaccines will present progress at the International Society for Vaccines (ISV) Annual Congress in Belgium on Oct 12-14, 2026
GPN Vaccines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access